Trial Profile
Efficacy and safety of a single-pill fix dose combination of azilsartan and amlodipine
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Jan 2017
Price :
$35
*
At a glance
- Drugs Amlodipine/azilsartan (Primary) ; Amlodipine/irbesartan; Amlodipine/valsartan
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms 4A study
- 19 Jan 2017 Status changed from recruiting to completed.
- 25 Feb 2015 Planned number of patients changed from 80 to 40 as per University Hospital Medical Information Network - Japan.
- 20 Jan 2015 New trial record